Enrollment complete in tivic health optimization study for its non-invasive vagus nerve stimulation device

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization study for tivic health's patent pending, non-invasive vagus nerve stimulation (vns) device. the study is being conducted by the feinstein institute of bioelectronic medicine. the objective of the study is to identify device parameters that optimally influence autonomi.
TIVC Ratings Summary
TIVC Quant Ranking